share_log

新銳醫藥：於二零二四年六月十八日舉行之股東週年大會之投票結果

NEW RAY MEDIC: POLL RESULTS OF THE ANNUAL GENERAL MEETINGHELD ON 18 JUNE 2024

Hong Kong Stock Exchange ·  Jun 18 19:55
Summary by Futu AI
新銳醫藥國際控股有限公司（「新銳醫藥」）於2024年6月18日召開股東週年大會，會上所有決議案均獲全數通過。該公司於2024年4月25日發布的通函中提出的決議包括授出購回及發行公司股份的一般授權，以及重選退任董事。在週年大會上，共有1,671,846,657股股份參與投票，投票結果顯示所有決議案均獲100%股東支持，包括批准經審核財務報表、董事會報告及核數師報告，重選王秋勤女士、褚雪平先生及梁志堅先生為董事，並授權董事會釐定董事酬金，續聘核數師，以及擴大發行或處置公司股份的一般授權。會議由卓佳證券登記有限公司監票，確保投票過程的準確性。
新銳醫藥國際控股有限公司（「新銳醫藥」）於2024年6月18日召開股東週年大會，會上所有決議案均獲全數通過。該公司於2024年4月25日發布的通函中提出的決議包括授出購回及發行公司股份的一般授權，以及重選退任董事。在週年大會上，共有1,671,846,657股股份參與投票，投票結果顯示所有決議案均獲100%股東支持，包括批准經審核財務報表、董事會報告及核數師報告，重選王秋勤女士、褚雪平先生及梁志堅先生為董事，並授權董事會釐定董事酬金，續聘核數師，以及擴大發行或處置公司股份的一般授權。會議由卓佳證券登記有限公司監票，確保投票過程的準確性。
New Ray Medic International Holdings Limited ("New Ray Medic") held its annual shareholders' meeting on June 18, 2024 and all proposed resolutions were passed with full support. The resolutions proposed in the company's communication released on April 25, 2024, including general authorization to issue repurchase and company shares, as well as re-election of retired directors, were approved. A total of 1,671,846,657 shares participated in the voting at the annual meeting, and the voting results showed that all proposed resolutions received 100% support from the shareholders, including the approval of audited financial statements, board reports, and auditor's reports, re-election of Ms. Wang Qiuqin, Mr. Chu Xueping, and Mr. Liang Zhijian as directors, and authorization for the board of directors to determine director remuneration, re-appoint the auditor, and expand general authorization for the issuance or disposal of company shares. The meeting was monitored by JiaZheng Securities Registration Co., Ltd. to ensure the accuracy of the voting process.
New Ray Medic International Holdings Limited ("New Ray Medic") held its annual shareholders' meeting on June 18, 2024 and all proposed resolutions were passed with full support. The resolutions proposed in the company's communication released on April 25, 2024, including general authorization to issue repurchase and company shares, as well as re-election of retired directors, were approved. A total of 1,671,846,657 shares participated in the voting at the annual meeting, and the voting results showed that all proposed resolutions received 100% support from the shareholders, including the approval of audited financial statements, board reports, and auditor's reports, re-election of Ms. Wang Qiuqin, Mr. Chu Xueping, and Mr. Liang Zhijian as directors, and authorization for the board of directors to determine director remuneration, re-appoint the auditor, and expand general authorization for the issuance or disposal of company shares. The meeting was monitored by JiaZheng Securities Registration Co., Ltd. to ensure the accuracy of the voting process.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.